Collectively, our results suggest that Rho/ROCK could regulate the Hippo pathway through additional mechanisms besides LATS1/2, and that kinase inhibitors of Rho/ROCK may have therapeutic roles for mesothelioma treatment through regulation of the Hippo pathway. Here, LATS1 is linked to mesothelioma.